Richard Vickers

Utilizing graph machine learning within drug discovery and development

Thomas Gaudelet, Ben Day, Arian R. Jamasb et al. · Briefings in Bioinformatics · 2021 · 282 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +17

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

Richard Vickers, Glenn Tillotson, Richard Nathan et al. · The Lancet Infectious Diseases · 2017 · 117 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases

Edward W. Brooke, Stephen G. Davies, Andrew W. Mulvaney et al. · Bioorganic & Medicinal Chemistry · 2003 · 85 citations

Life Sciences, Biochemistry, Microbiology +4

Discovery of 2-Arylbenzoxazoles as Upregulators of Utrophin Production for the Treatment of Duchenne Muscular Dystrophy

Daniel Chancellor, Kay E. Davies, Olivier De Moor et al. · Journal of Medicinal Chemistry · 2011 · 77 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs)

Edward W. Brooke, Stephen G. Davies, Andrew W. Mulvaney et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 67 citations

Life Sciences, Microbiology, Pharmacology +12